Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
China Isotope & Radiation Corp. ( (HK:1763) ) has issued an announcement.
China Isotope & Radiation Corporation has announced the launch of a new isotope separation technology called the ‘Adsorption Trapper’ by its subsidiary, Chengdu Gaotong Isotope Co., Ltd. This innovative technology utilizes fourth-generation MOF materials to enhance nuclear medicine and nuclear fusion development, offering high purity and efficiency at a lower cost. The advancement is expected to significantly impact the national economy by supporting key areas such as nuclear medicine and biomedical research, while also reducing China’s reliance on imported high-end isotopes.
The most recent analyst rating on (HK:1763) stock is a Buy with a HK$18.00 price target. To see the full list of analyst forecasts on China Isotope & Radiation Corp. stock, see the HK:1763 Stock Forecast page.
More about China Isotope & Radiation Corp.
China Isotope & Radiation Corporation (CIRC) operates in the nuclear technology industry, focusing on the development and application of isotopes. The company provides products and services that cater to advanced nuclear medicine and controlled nuclear fusion, with a market focus on establishing a stable and independent isotope supply chain.
Average Trading Volume: 297,498
Technical Sentiment Signal: Buy
Current Market Cap: HK$5.13B
For a thorough assessment of 1763 stock, go to TipRanks’ Stock Analysis page.